What is the Usana Health Sciences, Inc. stock price forecast?

Usana Health Sciences, Inc. is currently trading at $19.01. View real-time AI analysis on Alpha Lenz.

What is Usana Health Sciences, Inc. insider trading activity?

View the latest insider trading data for Usana Health Sciences, Inc. on Alpha Lenz.

What is Usana Health Sciences, Inc.'s P/E ratio?

Usana Health Sciences, Inc.'s P/E ratio is 32.7.

Usana Health Sciences, Inc.

NYSE · USNA

$19.01-0.40(-2.06%)Pre-market

Ask about Usana Health Sciences, Inc.'s future dividend policy...

Alpha Chat Insight

“Usana Health Sciences, Inc. trades at a P/E of 32.7 (premium valuation) with modest ROE of 2.0%.”

Ask for details →

Company Overview

Usana Health Sciences, Inc. is a prominent player in the healthcare and wellness sector, primarily focused on the development and distribution of nutritional supplements and personal care products. The company is renowned for its high-quality vitamins, dietary supplements, and skin and personal care items, aiming to enhance well-being and support healthy living. Usana operates on a global scale, selling its products through a direct selling model, which not only markets its portfolio but also empowers entrepreneurs around the world. Established in 1992, Usana Health Sciences has carved a niche in the wellness industry by prioritizing scientific research and development to ensure product efficacy and safety. The company's innovative approach and dedication to quality have made it a trusted name among health-conscious consumers and medical professionals alike. Usana plays a significant role in the broader health and wellness market, contributing to the global trend towards preventive health measures and personalized healthcare solutions.

CEOMr. Jim Brown

Websitehttps://www.usana.com

SectorConsumer Defensive

IndustryPackaged Foods

Employees1,700

Company Statistics

FY 2025

Profile

$352.35MMarket Cap

$925.26MRevenue

0.00Shares Out

1,700Employees

Margins

78.29%Gross

10.32%EBITDA

5.50%Operating

4.49%Pre-Tax

1.24%Net

Valuation

32.75P/E

0.66P/B

0.38EV/Sales

2.79EV/EBITDA

41.33P/FCF

Growth (CAGR)

-2.51%Rev 3Yr

-4.00%Rev 5Yr

-22.11%Op Inc 3Yr

-22.03%Op Inc 5Yr

-45.10%Net Inc 3Yr

-37.94%Net Inc 5Yr

Returns

1.54%ROA

2.02%ROE

5.68%ROIC

Financial Health

$158.38MCash & Cash Equivalents

$-1.74MNet Debt

26.72%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Usana Health Sciences, Inc. trades at a P/E of 32.7 (premium valuation) with modest ROE of 2.0%.”

Ask for details →

Frequently Asked Questions

Usana Health Sciences, Inc. (ticker: USNA) is a company listed on NYSE in the Consumer Defensive sector (Packaged Foods). It has approximately 1,700 employees. Market cap is $352M.

The current price is $19.01 with a P/E ratio of 32.75x and P/B of 0.66x.

ROE is 2.02% and operating margin is 5.50%. Annual revenue is $925M.